本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Humacyte, Inc.

0.7012
+0.03905.89%
盤前0.71000.0088+1.25%04:25 EDT
成交量:592.10萬
成交額:417.31萬
市值:1.95億
市盈率:-1.41
高:0.7300
開:0.6630
低:0.6601
收:0.6622
52周最高:2.55
52周最低:0.5261
股本:2.78億
流通股本:2.45億
量比:0.58
換手率:2.42%
股息:- -
股息率:- -
每股收益(TTM):-0.4975
每股收益(LYR):-0.2582
淨資產收益率:-547.87%
總資產收益率:-49.87%
市淨率:6.24
市盈率(LYR):-2.72

資料載入中...

2024/08/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

重要事件披露

Form 8-K - Current report
2024/08/07

SEC問詢函

Form CORRESP - Correspondence
2024/07/31

重要事件披露

Form 8-K - Current report
2024/06/13

重要事件披露

Form 8-K - Current report
2024/06/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/04

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/10

重要事件披露

Form 8-K - Current report
2024/03/28

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/28

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/22

重要事件披露

Form 8-K - Current report